Stockscreener 앱 받기
1.58
1.94%
0.03
시간 외 거래:
1.57
-0.01
-0.63%
Pacific Biosciences Of California Inc 주식(PACB)의 최신 뉴스
PacBio (PACB) Q1 earnings report preview: What to look for - MSN
Pacific Biosciences of California pushes whole genome sequencing to transform newborn care - Traders Union
PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now? - Yahoo Finance
NGS-based RNA-seq Market Size Accelerating at 14.8% CAGR | By Key - openPR.com
AI powers deep genomics gains as Pacific Biosciences of California improves sequencing accuracy and reduces costs - Traders Union
MSN Money - MSN
Pacific Biosciences of California presents new AAV workflow to reduce partial snapback genomes - Traders Union
Pacific Biosciences of California (PACB) Projected to Post Quarterly Earnings on Thursday - MarketBeat
PACB Stock Price, Quote & Chart | PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) - ChartMill
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know - Yahoo Finance
PacBio wins Basecamp Research deal for Trillion Gene Atlas initiative - MSN
Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight - GlobeNewswire Inc.
PacBio and DNAstack collaborate on global HiFi genome network hub - MSN
Sequencing performance advances drive Pacific Biosciences of California to revamp SMRT Cell 101 resource - Traders Union
Here's why you should add PacBio stock to your portfolio now - MSN
Pacific Biosciences of California (PACB) laps the stock market: Here's why - MSN
Pacific Biosciences of California Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Pacific Biosciences of California Inc (PACB) News, Articles, Events & Latest Updates - Stocktwits
Pacific Biosciences of California launches PRISM San Diego, unveils SPRQ-Nx chemistry and Vega system - Traders Union
Pacific Biosciences of California (PACB) registers a bigger fall than the market: Important facts to note - MSN
[ARS] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SEC Filing - Stock Titan
PacBio (NASDAQ: PACB) plans 2026 virtual meeting, 16M-share equity plan boost - Stock Titan
Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN
Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
HiFi sequencing technology from Pacific Biosciences of California brings biodiversity into sharper focus - Traders Union
PacBio & Lucid Genomics Partner to Boost Data Analysis, Stock Up - Yahoo Finance
Pacific Biosciences of California (NASDAQ:PACB) Stock Rating Lowered by Zacks Research - MarketBeat
PacBio (PACB) Partners with Lucid Genomics for Enhanced Data Ana - GuruFocus
Pacific Biosciences of California names Lucid Genomics as official partner for HiFi sequencing analysis - Traders Union
PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing - marketscreener.com
PacBio and Lucid Genomics GmbH Announces Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing - marketscreener.com
Farmer Michele sells Pacific Biosciences (PACB) shares for $4510 - Investing.com
Pacific Biosciences of California reveals unified approach to structural variant detection in cancer research - Traders Union
PacBio Stock (PACB) Opinions on Covaris FFPE Workflow Announcement - Quiver Quantitative
Sumitomo Mitsui Trust Group Inc. Lowers Position in Pacific Biosciences of California, Inc. $PACB - MarketBeat
Pacific Biosciences stock (US6932471010): Is long-read sequencing strong enough to unlock biotech up - AD HOC NEWS
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of "Hold" from Brokerages - MarketBeat
PacBio Stock Up on New FFPE Workflow Boosting Cancer Sequencing - TradingView
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 - Sahm
Pacific Biosciences of California compares leading long read sequencing technologies on accuracy and cost - Traders Union
May 7: PacBio investors get first-quarter results call and webcast - Stock Titan
Top Players and Competitive Dynamics in the Digital Genome Market - openPR.com
Pacific Biosciences of California (PACB) Stock Analysis: Exploring a 56% Potential Upside in Innovative Genomic Solutions - DirectorsTalk Interviews
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples - Sahm
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today - Yahoo Finance
PacBio, Covaris develop workflow for FFPE tissue sequencing By Investing.com - Investing.com Canada
Archived tumor samples gain long-read DNA workflow with 60% phasing - Stock Titan
0.41%
0.93%
자본화:
|
볼륨(24시간):